{"id":"transdermal-lidocaine-patch","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Skin irritation or erythema at application site"},{"rate":"1-5","effect":"Allergic contact dermatitis"},{"rate":"<1","effect":"Mild systemic effects (dizziness, headache) from transdermal absorption"}]},"_chembl":{"chemblId":"CHEMBL79","moleculeType":"Small molecule","molecularWeight":"234.34"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lidocaine is a local anesthetic that penetrates the skin and underlying tissues to reversibly inhibit sodium influx in nerve cell membranes, thereby preventing depolarization and conduction of pain impulses. The transdermal patch formulation provides sustained, localized delivery to affected areas, minimizing systemic absorption and side effects compared to oral or injectable routes.","oneSentence":"Lidocaine blocks sodium channels in nerve fibers, interrupting pain signal transmission when applied topically through a transdermal patch.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:50.039Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Postherpetic neuralgia (localized neuropathic pain)"},{"name":"Localized pain relief"}]},"trialDetails":[{"nctId":"NCT07060976","phase":"NA","title":"To Check Dermatological Safety of Test Products by 24 Hours Patch Testing","status":"COMPLETED","sponsor":"Novamed Laboratories Pvt. Ltd.","startDate":"2025-07-21","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT03810235","phase":"PHASE4","title":"The OBstetric Lidocaine Patch (OBLido) Trial","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-02-15","conditions":"Pain, Postoperative","enrollment":66},{"nctId":"NCT05694858","phase":"PHASE1, PHASE2","title":"Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting","status":"RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2025-02-17","conditions":"Glaucoma, Cataract, Ophthalmological Disorder","enrollment":154},{"nctId":"NCT05714631","phase":"PHASE4","title":"Lidocaine Patches in Elderly Patients With Traumatic Rib Fractures","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2023-10-01","conditions":"Rib Fractures","enrollment":5},{"nctId":"NCT03342079","phase":"NA","title":"Effectiveness of Nitrous Oxide 50% for Reducing Pain and Distress Associated with Needle-stick in Children","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2014-03","conditions":"Local Anesthetic Efficacy","enrollment":""},{"nctId":"NCT05096494","phase":"PHASE2","title":"Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain","status":"COMPLETED","sponsor":"Scilex Pharmaceuticals, Inc.","startDate":"2022-04-29","conditions":"Moderate to Severe Acute Lower Back Pain","enrollment":75},{"nctId":"NCT04144192","phase":"PHASE1","title":"Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects","status":"COMPLETED","sponsor":"Scilex Pharmaceuticals, Inc.","startDate":"2014-04-28","conditions":"Healthy","enrollment":58},{"nctId":"NCT03301766","phase":"PHASE4","title":"Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients","status":"WITHDRAWN","sponsor":"Cook County Health","startDate":"2017-03-10","conditions":"Low Back Pain","enrollment":""},{"nctId":"NCT05866653","phase":"PHASE2","title":"Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-03-25","conditions":"Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients","enrollment":90},{"nctId":"NCT05078463","phase":"PHASE2","title":"Efficacy of Transdermal Microneedle Patch for Topical Anesthesia Enhancement in Paediatric Thalassemia Patients","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2021-09-15","conditions":"Thalassemia in Children","enrollment":20},{"nctId":"NCT05187494","phase":"NA","title":"Enhancing the Efficiency of EMLA Cream in Palatal Anesthesia for Children","status":"COMPLETED","sponsor":"Damascus University","startDate":"2021-05-20","conditions":"Extrusion of Tooth","enrollment":75},{"nctId":"NCT05106400","phase":"PHASE1","title":"Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches","status":"COMPLETED","sponsor":"Scilex Pharmaceuticals, Inc.","startDate":"2021-07-01","conditions":"Healthy","enrollment":24},{"nctId":"NCT03310970","phase":"PHASE4","title":"Pharmacokinetics of Lidocaine in Healthy Adults","status":"COMPLETED","sponsor":"Nicole K Brogden","startDate":"2018-03-14","conditions":"Healthy","enrollment":23},{"nctId":"NCT03472469","phase":"PHASE4","title":"MAST Trial: Multi-modal Analgesic Strategies in Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Nonspecific Pain Post Traumatic Injury","enrollment":1561},{"nctId":"NCT03348735","phase":"PHASE4","title":"Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment","status":"TERMINATED","sponsor":"University Hospital, Antwerp","startDate":"2018-12-03","conditions":"Neuropathic Pain","enrollment":33},{"nctId":"NCT04169854","phase":"PHASE3","title":"Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2020-10-15","conditions":"Postoperative Pain, Lidocaine","enrollment":180},{"nctId":"NCT04518189","phase":"NA","title":"Transdermal Lidocaine for Pain Control During Hysterosalpingography","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":120},{"nctId":"NCT04517890","phase":"NA","title":"Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":200},{"nctId":"NCT04518202","phase":"NA","title":"Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":200},{"nctId":"NCT03145207","phase":"EARLY_PHASE1","title":"PK and DPK of Lidocaine Dermal Products","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2016-12-14","conditions":"Heat Effect","enrollment":14},{"nctId":"NCT01086150","phase":"PHASE2, PHASE3","title":"Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy","status":"COMPLETED","sponsor":"Albany Medical College","startDate":"2009-10","conditions":"Diabetic Peripheral Neuropathy","enrollment":51},{"nctId":"NCT03120351","phase":"NA","title":"Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2009-09","conditions":"Perioperative Chest Pain","enrollment":80},{"nctId":"NCT04322760","phase":"NA","title":"Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery","status":"COMPLETED","sponsor":"Tanta University","startDate":"2016-12-01","conditions":"Dexmedetomidine, Lidocaine 5% Patch, Arthroscopic Knee Surgery","enrollment":40},{"nctId":"NCT03500211","phase":"PHASE4","title":"Post-Op Lidocaine Patch","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-03-13","conditions":"Pain, Postoperative","enrollment":50},{"nctId":"NCT04238208","phase":"PHASE4","title":"The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2019-01-10","conditions":"Diabetic Nerve Problems, Diabetic Neuropathy, Diabetic Complications Neurological","enrollment":290},{"nctId":"NCT03629041","phase":"PHASE1","title":"A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity","status":"COMPLETED","sponsor":"Innoture Ltd","startDate":"2018-07-31","conditions":"Topical Anaesthesia","enrollment":16},{"nctId":"NCT01416116","phase":"PHASE4","title":"Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2011-07-06","conditions":"or Peripheral Nerve Injury (PNI), Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)","enrollment":122},{"nctId":"NCT02750969","phase":"PHASE4","title":"Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment","status":"UNKNOWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2016-04","conditions":"Tinnitus","enrollment":58},{"nctId":"NCT00589979","phase":"PHASE2","title":"Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2007-03","conditions":"Osteoarthritis of the Knee","enrollment":169},{"nctId":"NCT02088866","phase":"EARLY_PHASE1","title":"Commercial Lidocaine Patch as a Treatment for Ear-ringing","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2014-03","conditions":"Tinnitus","enrollment":30},{"nctId":"NCT02240628","phase":"PHASE4","title":"Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2014-08","conditions":"Pain on IV Injection of Propofol.","enrollment":76},{"nctId":"NCT02749123","phase":"NA","title":"Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis","status":"UNKNOWN","sponsor":"J.A.R. Laboratories","startDate":"2016-04","conditions":"Back Pain, Arthritis","enrollment":100},{"nctId":"NCT02410460","phase":"NA","title":"Anesthetics in Rhytidoplasty - A Comparison Study","status":"COMPLETED","sponsor":"Mercy Facial Plastic Surgery Center","startDate":"2013-09","conditions":"Rhytidoplasty","enrollment":30},{"nctId":"NCT02066818","phase":"EARLY_PHASE1","title":"Injectable Lidocaine Versus Lidocaine/Tetracaine Patch for the Incision and Drainage of Skin Abscesses","status":"COMPLETED","sponsor":"East Carolina University","startDate":"2008-01","conditions":"Cutaneous Abscess, Pain","enrollment":20},{"nctId":"NCT00904111","phase":"PHASE2","title":"A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2004-08","conditions":"Chronic Low Back Pain","enrollment":215},{"nctId":"NCT01602757","phase":"PHASE1","title":"Pharmacokinetic Study of Synera in Healthy Volunteers","status":"COMPLETED","sponsor":"ZARS Pharma Inc.","startDate":"2010-02","conditions":"Healthy","enrollment":12},{"nctId":"NCT01576770","phase":"PHASE4","title":"In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction?","status":"UNKNOWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2012-04","conditions":"Pain on Propofol IV Injection","enrollment":80},{"nctId":"NCT00747669","phase":"PHASE4","title":"Pharmacokinetic Study of Synera™ in Neonates and Infants","status":"SUSPENDED","sponsor":"ZARS Pharma Inc.","startDate":"2008-09","conditions":"Pain","enrollment":11},{"nctId":"NCT00991068","phase":"PHASE2","title":"Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"ZARS Pharma Inc.","startDate":"2009-09","conditions":"Carpal Tunnel Syndrome","enrollment":24},{"nctId":"NCT01544283","phase":"PHASE2","title":"Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome","status":"UNKNOWN","sponsor":"Injury Care Medical Center","startDate":"2012-03","conditions":"Shoulder Pain","enrollment":60},{"nctId":"NCT00904462","phase":"PHASE2","title":"Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2004-08","conditions":"Osteoarthritis, Knee","enrollment":224}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Actavis US","NDC 0591-3525-30","5% Commercially Available Transdermal Lidocaine"],"phase":"marketed","status":"active","brandName":"Transdermal Lidocaine Patch","genericName":"Transdermal Lidocaine Patch","companyName":"University of Wisconsin, Madison","companyId":"university-of-wisconsin-madison","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lidocaine blocks sodium channels in nerve fibers, interrupting pain signal transmission when applied topically through a transdermal patch. Used for Postherpetic neuralgia (localized neuropathic pain), Localized pain relief.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}